{"title":"Pharmacologic problems in shock research.","authors":"H R Adams","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Recent advances with receptor-selective agonists and antagonists have provided great impetus to the deployment of drugs as experimental tools in cardiovascular research. Often overlooked, however, is the important limitation that few exogenous chemicals actually exert only one biologic action. This discussion appraised several prototype drugs used in this field, and theorized how a lack of consideration of subsidiary pharmacologic actions may lead to over-simplified interpretations of drug-based data.</p>","PeriodicalId":75453,"journal":{"name":"Advances in shock research","volume":"10 ","pages":"3-8"},"PeriodicalIF":0.0000,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in shock research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Recent advances with receptor-selective agonists and antagonists have provided great impetus to the deployment of drugs as experimental tools in cardiovascular research. Often overlooked, however, is the important limitation that few exogenous chemicals actually exert only one biologic action. This discussion appraised several prototype drugs used in this field, and theorized how a lack of consideration of subsidiary pharmacologic actions may lead to over-simplified interpretations of drug-based data.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
